IL6 and COVID-19: Notably olfactory loss, and many neuropsychiatric disorders are associated with high levels of interleukin-6 (IL-6), an inflammatory marker which is also implicated in the cytokine storm in COVID-19 patients (Gialluisi et al., 2020; de Erausquin et al., 2021).